×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 |
Fabino Life Sciences Limited has established itself in the Healthcare sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.
| Metrics | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 |
|---|---|---|---|---|
| Sales | 2.2 | 1.0 | 2.3 | 0.9 |
| Expenses | 2.0 | 1.0 | 2.3 | 0.9 |
| Operating Profit | 0.1 | 0.0 | 0.0 | 0.1 |
| OPM % | 6.83% | 0.38% | 0.91% | 8.09% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.1 | 0.0 | 0.0 | 0.1 |
| Tax % | -16.1% | -18.2% | 100% | -25.4% |
| Net Profit | 0.1 | 0.0 | 0.0 | 0.0 |
| EPS in Rs | 0.47 | 0.04 | 0.01 | 0.22 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | 25% |
| TTM: | 188% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 19% |
| TTM: | 400% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -1% |
| 1 Year: | -17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -122% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -1% |
| 1 Year: | -17% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|